Urol. praxi. 2026;27(2):108-110 | DOI: 10.36290/uro.2025.097

Indications and guidelines for active surveillance in men with prostate cancer

doc. MUDr. Otakar Čapoun, Ph.D., FEBU
Urologická klinika, 1. LF UK a VFN, Praha

Active surveillance represents a standard management strategy for localized prostate cancer in men with low-risk disease and selected patients with favorable intermediate-risk features. The aim is to delay or avoid curative treatment in those with a low risk of progression, thereby preserving quality of life without compromising oncologic safety. The use of magnetic resonance and targeted biopsies improves patient selection and minimizes the risk of missing clinically significant tumors.

Keywords: prostate cancer, active surveillance, magnetic resonance, fusion biopsy.

Accepted: December 5, 2025; Prepublished online: December 5, 2025; Published: June 10, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čapoun O. Indications and guidelines for active surveillance in men with prostate cancer. Urol. praxi. 2026;27(2):108-110. doi: 10.36290/uro.2025.097.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 10.6.2027

    References

    1. EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5.
    2. Prostate Cancer Research International: Active Surveillance. https://www.prias-project.org/. [cited 3.11.2025].
    3. Caglic I, Sushentsev N, Syer T, et al. Biparametric MRI in prostate cancer during active surveillance: is it safe? Eur Radiol. 2024;34(10):6217-6226. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.